Publications by authors named "Neil Minton"

Claim this Profile
L
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial.
Bruce Ac Cree, Krzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi, Amit Bar-Or, Neil Minton

Mult Scler· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program.
Krzysztof W Selmaj, Jeffrey A Cohen, Giancarlo Comi, Amit Bar-Or, Douglas L Arnold, Neil Minton

Mult Scler Relat Disord· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis.
Evan S Dellon, Margaret H Collins, Marc E Rothenberg, Yehudith Assouline-Dayan, Larry Evans, Neil Minton

Clin Gastroenterol Hepatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections in patients with multiple sclerosis: A national cohort study in Sweden.
Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson, Sally Lee, Neil Minton

Mult Scler Relat Disord· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study.
Brian G Feagan, William J Sandborn, Silvio Danese, Douglas C Wolf, Wenzhong J Liu, Neil Minton

Lancet Gastroenterol Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden.
Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson, Sally Lee, Neil N Minton

Mult Scler J Exp Transl Clin· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study.
Rebecca Persson, Sally Lee, Marianne Ulcickas Yood, Michael Wagner, Neil Minton

Mult Scler Relat Disord· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial.
Giancarlo Comi, Ludwig Kappos, Krzysztof W Selmaj, Amit Bar-Or, Douglas L Arnold, Neil Minton

Lancet Neurol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.
Jeffrey A Cohen, Giancarlo Comi, Krzysztof W Selmaj, Amit Bar-Or, Douglas L Arnold, Neil Minton

Lancet Neurol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries.
Rebecca Persson, Sally Lee, Marianne Ulcickas Yood, Michael Wagner, Neil Minton

J Neurol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive pregnancy tests in females of reproductive potential receiving lenalidomide in the United States.
Carmen Castaneda, Neil Minton, Melinda Mezo, Damien Hirsch, Lisa Phillips

Leuk Lymphoma· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
L Mark Kao, Karen Bush, Roy Barnewall, James Estep, Frederic W Thalacker, Neil Minton

Antimicrob Agents Chemother· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects.
Wojciech Krzyzanski, William J Jusko, Mary C Wacholtz, Neil Minton, Wing K Cheung

Eur J Pharm Sci· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
Rohini Ramakrishnan, Wing K Cheung, Mary C Wacholtz, Neil Minton, William J Jusko

J Clin Pharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis